ESMO 2017: Daily Reporter

The ESMO 2017 Daily Reporter is the official news source for the ESMO congress, providing expert perspectives on controversial topics and session highlights, with live reporting and critical insights on data.

Read the Tuesday 12 September edition

Read the Monday 11 September edition

Read the Sunday 10 September edition

Read the Saturday 09 September edition

Read the Friday 08 September edition

Editorial Team

ESMO 2017 Daily Reporter Front Page

Editor-in-Chief: 
Giuseppe Curigliano, European Institute of Oncology, Milan, Italy

Associate Editors:
Evandro de Azambuja, Institute Jules Bordet, Brussels, Belgium
Rodrigo Dienstmann, Vall d'Hebron Institute of Oncology, Barcelona, Spain
Markus Joerger, Kantonsspital St. Gallen, St Gallen, Switzerland
Angela Lamarca, The Christie NHS Foundation Trust, Manchester, UK
Floriana Morgillo, Second University of Naples, Naples, Italy
Stefan Zimmermann, CHUV Lausanne University Hospital, Lausanne, Switzerland

Giuseppe Curigliano: Editor-in-Chief

ESMO 2017 here in Madrid promises to be a truly impressive Congress, with a scientific programme that blends cutting-edge science with evolving clinical practice.

Over the next five days, we at the Daily Reporter will help you to navigate this exciting and busy Congress. As well as bringing you reports on the latest ground-breaking data, we will be turning the spotlight on sessions and topics across multiple disciplines.

The ESMO 2017 Daily Reporter is the official news source for the ESMO annual congress, providing expert perspectives on hot topics and session highlights, with live reporting and critical insights on data. The content includes physician-authored expert editorials on current clinical issues in oncology, interviews with congress attendees, and recaps of key sessions and presentations. Our stellar Editorial Board–comprising me and Associate Editors Evandro de Azambuja, Markus Joerger, Floriana Morgillo and Stefan Zimmermann, Angela Lamarca and Rodrigo Dienstmann – draws on experience across therapeutic areas to ensure the wide appeal of the paper’s content.